Supporting its role as a regulator of IFNβ-induced genes, an intronic SNP in STARD13 was amongst eighteen that were replicated in a study of responders to IFNβ therapy in MS patients [56]. The gene discussed is IFNB1; the disease is myeloid sarcoma.